Literature DB >> 33547555

First-in-human study of an 18F-labeled boramino acid: a new class of PET tracers.

Xiaoli Lan1,2, Kevin Fan3, Weibo Cai4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33547555      PMCID： PMC8339148          DOI： 10.1007/s00259-021-05227-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  33 in total

1.  Novel matrix metalloproteinase inhibitor [18F]marimastat-aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer.

Authors:  Ulrich auf dem Keller; Caroline L Bellac; Ying Li; Yuanmei Lou; Philipp F Lange; Richard Ting; Curtis Harwig; Reinhild Kappelhoff; Shoukat Dedhar; Michael J Adam; Thomas J Ruth; François Bénard; David M Perrin; Christopher M Overall
Journal:  Cancer Res       Date:  2010-08-20       Impact factor: 12.701

2.  Arylfluoroborates and alkylfluorosilicates as potential PET imaging agents: high-yielding aqueous biomolecular 18F-labeling.

Authors:  Richard Ting; Michael J Adam; Thomas J Ruth; David M Perrin
Journal:  J Am Chem Soc       Date:  2005-09-28       Impact factor: 15.419

3.  Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.

Authors:  Xiaoxia Xu; Hua Zhu; Fei Liu; Yan Zhang; Jianhua Yang; Lifang Zhang; Lin Zhu; Nan Li; Hank F Kung; Zhi Yang
Journal:  Clin Nucl Med       Date:  2018-11       Impact factor: 7.794

4.  Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.

Authors:  Sriram Venneti; Mark P Dunphy; Hanwen Zhang; Kenneth L Pitter; Patrick Zanzonico; Carl Campos; Sean D Carlin; Gaspare La Rocca; Serge Lyashchenko; Karl Ploessl; Daniel Rohle; Antonio M Omuro; Justin R Cross; Cameron W Brennan; Wolfgang A Weber; Eric C Holland; Ingo K Mellinghoff; Hank F Kung; Jason S Lewis; Craig B Thompson
Journal:  Sci Transl Med       Date:  2015-02-11       Impact factor: 17.956

5.  18F-Boramino acid PET/CT in healthy volunteers and glioma patients.

Authors:  Zhu Li; Ziren Kong; Junyi Chen; Jiyuan Li; Nan Li; Zhi Yang; Yu Wang; Zhibo Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-15       Impact factor: 9.236

Review 6.  11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

Authors:  Tarun Singhal; Tanjore K Narayanan; Viney Jain; Jogeshwar Mukherjee; Joseph Mantil
Journal:  Mol Imaging Biol       Date:  2007-10-24       Impact factor: 3.488

7.  Kit-like 18F-labeling of RGD-19F-arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging.

Authors:  Zhibo Liu; Ying Li; Jerome Lozada; May Q Wong; Jennifer Greene; Kuo-Shyan Lin; Donald Yapp; David M Perrin
Journal:  Nucl Med Biol       Date:  2013-06-27       Impact factor: 2.408

8.  Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging.

Authors:  Zhibo Liu; Maral Pourghiasian; François Bénard; Jinhe Pan; Kuo-Shyan Lin; David M Perrin
Journal:  J Nucl Med       Date:  2014-06-26       Impact factor: 10.057

Review 9.  Insight into the Development of PET Radiopharmaceuticals for Oncology.

Authors:  Joseph Lau; Etienne Rousseau; Daniel Kwon; Kuo-Shyan Lin; François Bénard; Xiaoyuan Chen
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

Review 10.  Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors.

Authors:  Jan-Michael Werner; Philipp Lohmann; Gereon R Fink; Karl-Josef Langen; Norbert Galldiks
Journal:  Molecules       Date:  2020-03-24       Impact factor: 4.411
View more
  1 in total

1.  Larger 18F-fluoroboronotyrosine (FBY) active volume beyond MRI contrast enhancement in diffuse gliomas than in circumscribed brain tumors.

Authors:  Ziren Kong; Zhu Li; Junyi Chen; Wenbin Ma; Yu Wang; Zhi Yang; Zhibo Liu
Journal:  EJNMMI Res       Date:  2022-04-18       Impact factor: 3.434
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.